The 2018 NDARC Annual Research Symposium was held on Monday, 8 October 2018. Thanks to all who presented and attended on the day.
A number of presentations from the event are available below. A selection of images from the event are also available online.
For any additional enquiries please contact ndarc.symposium@unsw.edu.au.
Click here to download the program
Click here to download the abstract booklet (including the event program and poster list)
8.30 – 9.00am | Registration |
9.00 – 9.10am | Acknowledgement of Country |
9.10 – 9.15am | Welcome Professor Rodney Phillips Dean, UNSW Medicine |
Plenary One Session Chair: Mr Chris Killick-Moran |
|
9.15 – 10.00am | Keynote Address: Embedding evaluation and learning into the delivery of routine services Professor Louis Fiore Professor of Medicine and Professor Epidemiology Boston University School of Public Health, VA Boston Healthcare System |
10.00 – 10.20am | Harnessing clinical informatics to transform clinical research: An overview of the NSW AoD Clinical Outcomes and Quality Indicators system Conjoint Professor Nicholas Lintzeris Director Drug and Alcohol Services, South Eastern Sydney Local Health District |
10.20 – 10.40am | The development and testing of a framework to increase the uptake of integrated care into routine service delivery by drug and alcohol and mental health clinical services Ms Catherine Foley Doctoral Candidate, NDARC |
10.40 -10.50am |
Two minute poster presentations |
10.50 -11.10am | Morning Tea |
Plenary Two Drug Trends Session Chair: Mr Daniel Madeddu |
|
11.10 – 11.30am | Emerging trends in drug use, harms, and markets: Findings from Drug Trends 2018 Dr Amy Peacock NHMRC Early Career Research Fellow, NDARC |
11.30 – 11.50am | Availability and use of new and emerging psychoactive substances in Australia: Findings from Drug Trends 2018 Ms Rachel Sutherland Doctoral Candidate, Senior Research Officer Drug Trends Program, NDARC |
11.50 – 12.10pm | Trends in fentanyl availability, use and harms Australia: Findings from Drug Trends 2018 Associate Professor Raimondo Bruno University of Tasmania |
12.10 - 12.15pm |
Two minute poster presentation |
12.15 – 13.15pm | Breakout Sessions |
Breakout One: Challenges of translating research into policy Session Chair: Professor Louisa Degenhardt |
|
Translation of research into policy and practice: examples from smoking cessation Dr Hayden McRobbie Professor of Public Health Intervention Queen Mary University of London |
|
Discussion Panel Professor Michael Farrell |
|
Breakout Two: Responding to harms: Clinical treatment Session Chair: Associate Professor Timothy Dobbins |
|
Cytisine versus varenicline for smoking cessation: A single-blind randomised controlled clinical trial Dr Ryan Courtney Early Career Research Fellow, Cancer Institute New South Wales |
|
Monthly injections of long-acting buprenorphine for the treatment of opioid dependence Dr Briony Larance Senior Research Fellow, University of Wollongong |
|
The effect of treatment and retention in opioid substitution therapy on reducing crime among opioid dependent people Dr Natasa Gisev NHMRC Early Career Research Fellow, NDARC |
|
Screening for prescribed opioid dependence in primary care settings Associate Professor Suzanne Nielsen Monash University |
|
Breakout Three: Treatment within prison settings Session Chair: Dr Marian Shanahan |
|
Surveillance and Treatment of Prisoners with Hepatitis C Professor Andrew Lloyd Program Head Viral Immunology Systems Program The Kirby Institute |
|
Trial of depot buprenorphine in prisons |
|
The SNAP study – A randomised controlled trial of a brief intervention “SNAP” to prevent relapse to smoking after release from smoke-free prisons in the Northern Territory Professor Kate Dolan NDARC |
|
Alcohol Treatment within a prison setting Mr Michael Doyle Research Fellow at the Centre for Research Excellence (CRE) in Indigenous Health and Alcohol, University of Sydney |
|
Breakout Four: Prevention: working with Aboriginal communities Session Chair: Professor Anthony Shakeshaft |
|
Exploring the role of Aboriginal women in their families and communities: it’s impact on their health and implications for delivery of services Dr Anne-Marie Eades UNSW Scientia Fellow Faculty of Medicine, UNSW Sydney |
|
Cultures within cultures investigating conflict in Aboriginal communities and its influence on alcohol and drug related harms Ms Bonita Byrne Masters by Research Candidate, NDARC |
|
The impact of community-developed responses to alcohol-related harms: demonstrating the value of community/researcher partnerships Dr Alice Munro and Dr Mieke Snijder Research Capacity Building Manager Western NSW LHD and Postdoctoral Researcher |
|
The experience of Aboriginal communities engaging in research Mr Jamie O'Neill CEO Murrin Bridge Aboriginal Lands Council |
|
13.15 – 14.15pm | Lunch (and poster viewing) |
14.15 – 15.20pm | Breakout Sessions |
Breakout Five: Young People, Alcohol and Other Drugs Session Chair: Dr Amy Peacock |
|
Adverse adult consequences of different alcohol use patterns in adolescence Mr Philip Clare Doctoral Candidate and Biostatistician, NDARC |
|
What the APSALS and consortium data tell us about taking a population level approach rather than targeting heavy/binge drinkers Professor Kypros Kypri School of Medicine and Public Health, University of Newcastle, Australia |
|
The effectiveness and cost-benefit of an NGO delivered program for high-risk young people, and integrating research into multiple NGO services nationally Ms Skye Bullen Masters by Research Candidate, NDARC |
|
Steroids and harm reduction: working with young adults who use performance and image enhancing drugs (PIEDs) Dr Katinka Van de Ven and Mr William Wood Research Fellow, NDARC MSIC |
|
Breakout Six: Responding to harms: The co-creation of a research agenda with treatment services Session Chair: Professor Anthony Shakeshaft |
|
Co-creation of new knowledge is at the heart of embedding research into routine service delivery, but what is it and how often is it done? Ms Tania Pearce Doctoral Candidate, University of New England |
|
The impact of research on Aboriginal residential rehabilitation services Mr Joe Coyte CEO of The Glen Central Coast Drug and Alcohol Rehabilitation Centre |
|
The experience of consumers involved in the co-design and implementation of a model of Integrated Care: A facilitated discussion Panel discussion |
|
Breakout Seven: Comorbidity Session Chair: Professor Louisa Degenhardt |
|
Review of psychiatric consequences of methamphetamine use Dr Emily Stockings NHMRC Early Career Research Fellow, NDARC |
|
The impact of comorbid mental health disorders on receipt of substance use disorder treatment Chrianna Bharat Research Fellow, NDARC |
|
Psychostimulant use and fatal stroke in young adults: a national study Professor Shane Darke NDARC |
|
Breakout Eight: Criminal Justice Responses Session Chair: Dr Sarah Larney |
|
Does imprisoning drink-drivers reduce the risk of drink-driving? Dr Don Weatherburn Director of the NSW Bureau of Crime Statistics and Research |
|
Drug-related police encounters across the globe: How does Australia compare? Dr Caitlin Hughes Senior Research Fellow, NDARC |
|
Understanding how a high-level drug trafficking network in Australia adapted to changes in its drug supply Mr Matthew O’Reilly Doctoral Candidate, NDARC |
|
15.20 – 15.40pm | Afternoon Tea |
Plenary Three Session Chair: Professor Michael Farrell | |
15.40 – 16.25pm | Enhancing quality health care for people who use drugs Professor Julie Bruneau Professor in the Department of Family Medicine, University of Montreal |
16.25 – 16.45pm | National Centre for Clinical Research Excellence on Emerging Drugs (NCCRED) Associate Professor Nadine Ezard Director NCCRED and Clinical Director Drug and Alcohol Services, St Vincent’s Hospital |
16.45 – 17.05pm | HCV elimination among people who inject drugs: Feasibility and future requirements Associate Professor Jason Grebely Senior Research Fellow, The Kirby Institute |
17.05 – 17.15pm | Discussion and Wrap (Will include announcement of People’s Choice poster winner) Professor Michael Farrell Director, NDARC |
17.15 – 18.15pm | Symposium Drinks |
Registration for the 2018 NDARC Annual Research Symposium is now open. Please click here to register.
Keynote speakers:
Professor Louis Fiore
Dr Louis Fiore is a Physician-scientist-manager-innovator with board certifications in internal medicine, oncology and hematology. He is a Professor of Epidemiology at the Boston University School of Medicine. Additionally, he is currently the Executive Director of a research group within the Department of Veterans Affairs The Center (MAVERIC) provides the Department nationally with expertise in large scale clinical trials and bioinformatics. Current research and trials are underway.
Dr Hayden McRobbie
Hayden McRobbie is Professor in Public Health Interventions at Barts and The London School of Medicine and Dentistry, Queen Mary University of London (UK), Clinical Director of the Dragon Institute for Innovation (NZ) and a Medical Smoking Cessation Specialist at Counties Manukau District Health Board.
After completing his medical degree, he went on to study in London and gained a PhD in medical psychology. He now has over 18 years’ experience in the provision of behaviour change interventions in the fields of smoking cessation and weight management. Hayden has played a key role in Tobacco Control in New Zealand and is also the Clinical Champion for Child Wellbeing for the New Zealand Ministry of Health.
Dr Julie Bruneau
Dr Julie Bruneau is Professor in the Department of Family and Emergency Medicine at Université de Montréal and clinical researcher at the Centre Hospitalier de l’Université de Montréal (CHUM) research center. She is recognized as a leader in addiction medicine in Canada, and was central in the development of access to integrated care for people who inject drugs, including Opiate Agonist Treatment (OAT) and syringe Distribution Program networks in the province of Quebec.
Over the past 20 years, her research contributed to a better understanding of factors impeding and facilitating harm reduction efforts to reduce HIV and HCV transmission among persons who inject drugs. Dr Bruneau is the scientific director of the Quebec-Atlantic node of Canadian Research Initiative on Drug Misuse (CRISM), a network conducting a number of trials and implementation science projects to address the opioid crisis and develop better care for people who use drugs in Canada.